BENDAMUSTINE HYDROCHLORIDE FOR INJECTION

Accord Healthcare Inc🇨🇦 Health Canada

Approval Id: 369271c87c9b2cb0
Drug Approval Canada Name: BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Product Name: BENDAMUSTINE HYDROCHLORIDE FOR INJECTION
Status: Marketed
Status Date: 2021-03-02
Original Market Date: 2021-03-02
Din: 02496852
Drug Class: Human
Dosage Form: Powder For Solution
Route Of Administration: Intravenous
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L01AA09 BENDAMUSTINE
Atc Name: l 01 aa 09
Aig Number: 0153268001
Company Name: Accord Healthcare Inc
Company Address: 3535 Boulevard St-Charles, Suite 704, Kirkland, Quebec, Canada, H9H 5B9
Company Detail Path: /organization/accord-healthcare-inc

BENDAMUSTINE HYDROCHLORIDE

25 MG / VIAL

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

369271c87c9b2cb0

Type

Standard